The ISCHEMIA Trial: What is the Message for the Interventionalist?

Código QR

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Guardado en:

Detalles Bibliográficos
Autores principales:	Emmanuel Ako, Sukhjinder Nijjer, Abtehale Al-Hussaini, Raffi Kaprielian
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/00bbbc22f432496494e9e1b57cbaeefb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The EXCEL Trial: The Interventionalists’ Perspective
por: George William Hunter, et al.
Publicado: (2021)

What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
por: Islam Y Elgendy, et al.
Publicado: (2020)

What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
por: Kreton Mavromatis, et al.
Publicado: (2020)

What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021)

The ISCHEMIA Trial: And the Winner Is… the Patient
por: Pablo Avanzas, et al.
Publicado: (2021)

ISCHEMIA Trial: Key Questions and Answers
por: Jose Lopez-Sendon, et al.
Publicado: (2021)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
por: Jonathan Yap, et al.
Publicado: (2021)

BEST Endovascular Versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) Trial
por: Raghu Motaganahalli, et al.
Publicado: (2020)

Electrophysiology’s Identity Crisis: What our Clinical Trials Do and Do Not Say About Us
por: David J Callans, et al.
Publicado: (2020)

ISCHEMIA Trial and the Significance of MI
por: Eduardo A Arias, et al.
Publicado: (2020)

The role of directional atherectomy in critical-limb ischemia
por: Prakash Krishnan, et al.
Publicado: (2021)

Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers
por: Henry Seligman, et al.
Publicado: (2020)

Physical Activity after Cardiac EventS (PACES): a group education programme with subsequent text message support designed to increase physical activity in individuals with diagnosed coronary heart disease: a randomised controlled trial
por: Melanie J Davies, et al.
Publicado: (2021)

What is your diagnosis?
por: Uğur Nadir Karakulak, et al.
Publicado: (2021)

What is your diagnosis?
por: Yavuzer Koza, et al.
Publicado: (2021)

Acute Limb Ischemia in the Young: A Rare Case of Essential Thrombocytosis
por: Johanes Nugroho, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

Cerebrovascular ischemic event - what about the coronaries
por: Joseph C. Lee, et al.
Publicado: (2021)

What Cannot be Missed: Must-read Papers, 2018
por: Demosthenes G Katritsis
Publicado: (2019)

What Cannot Be Missed: Important Publications on Electrophysiology in 2019
por: Andrew Grace, et al.
Publicado: (2020)

What Cannot Be Missed: Important Publications on Electrophysiology in 2020
por: Sanjiv M Narayan, et al.
Publicado: (2021)

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials
por: Danielle Haanschoten, et al.
Publicado: (2021)

Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021)

Medical Therapy Following Urgent/Emergent Revascularization in Peripheral Artery Disease Patients (Canadian Acute Limb Ischemia Registry [CANALISE I])
por: Eric Kaplovitch, BSc(H), MD, FRCPc, et al.
Publicado: (2021)

The EXCEL Trial: The Surgeons’ Perspective
por: Marjan Jahangiri, et al.
Publicado: (2020)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
por: Grace Shu-wen Chang, et al.
Publicado: (2020)

Incisional Hernia Following Open Abdominal Aortic Aneurysm Repair: A Contemporary Review of Risk Factors and Prevention
por: Thuy-My Nguyen, et al.
Publicado: (2020)

Reduced exercise capacity in the adult with repaired tetralogy of Fallot: More evidence. Now what to do?
por: Rose Tompkins, et al.
Publicado: (2021)

Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity
por: Astrid Hubert, et al.
Publicado: (2020)

The non-infectious effects of COVID-19 were fierce with the weakest: What lessons did we learn?
por: Aline Meza-Ramos, et al.
Publicado: (2021)

Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?
por: Shohreh Honarbakhsh, et al.
Publicado: (2021)

Aortic dissection type 1, windsock sign, neglected lead, and Kounis syndrome: What a coincidence!
por: Nicholas G. Kounis, et al.
Publicado: (2021)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Felipe Martínez
Publicado: (2021)

What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Sung Soo Kim MD, et al.
Publicado: (2021)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Ahmadreza Karimianpour, et al.
Publicado: (2021)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
por: Suzanne J Baron
Publicado: (2020)